New protocol may lead to improved patient outcomes
A robust, multidisciplinary team key to best possible outcomes
Viewpoints from Steven Wexner, MD
Cardiovascular drug affects cancer cell protein pathways
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Treating OSA could improve quality of life for liver disease patients
The clinical picture
New findings presented at ACS Clinical Congress 2017
Special training and care reduces readmission by 33 percent
Early-stage research offers hope
Helps patients who aren't good surgical candidates
Advertisement
Advertisement